518 related articles for article (PubMed ID: 17673906)
1. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.
Lee MK; Pardoux C; Hall MC; Lee PS; Warburton D; Qing J; Smith SM; Derynck R
EMBO J; 2007 Sep; 26(17):3957-67. PubMed ID: 17673906
[TBL] [Abstract][Full Text] [Related]
2. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Galliher AJ; Schiemann WP
Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
[TBL] [Abstract][Full Text] [Related]
3. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
6. Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway.
van Biesen T; Hawes BE; Luttrell DK; Krueger KM; Touhara K; Porfiri E; Sakaue M; Luttrell LM; Lefkowitz RJ
Nature; 1995 Aug; 376(6543):781-4. PubMed ID: 7651538
[TBL] [Abstract][Full Text] [Related]
7. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases.
Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y
Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
[TBL] [Abstract][Full Text] [Related]
10. ShcA mediates the dominant pathway to extracellular signal-regulated kinase activation during early thymic development.
Trampont P; Zhang L; Ravichandran KS
Mol Cell Biol; 2006 Dec; 26(23):9035-44. PubMed ID: 16982683
[TBL] [Abstract][Full Text] [Related]
11. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells.
Kim SI; Kwak JH; Na HJ; Kim JK; Ding Y; Choi ME
J Biol Chem; 2009 Aug; 284(33):22285-22296. PubMed ID: 19556242
[TBL] [Abstract][Full Text] [Related]
13. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.
Chen Y; Grall D; Salcini AE; Pelicci PG; Pouysségur J; Van Obberghen-Schilling E
EMBO J; 1996 Mar; 15(5):1037-44. PubMed ID: 8605873
[TBL] [Abstract][Full Text] [Related]
14. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells.
Arany I; Faisal A; Nagamine Y; Safirstein RL
J Biol Chem; 2008 Mar; 283(10):6110-7. PubMed ID: 18174162
[TBL] [Abstract][Full Text] [Related]
15. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
[TBL] [Abstract][Full Text] [Related]
16. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
[TBL] [Abstract][Full Text] [Related]
17. PKC delta phosphorylates p52ShcA at Ser29 to regulate ERK activation in response to H2O2.
Hu Y; Kang C; Philp RJ; Li B
Cell Signal; 2007 Feb; 19(2):410-8. PubMed ID: 16963224
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
[TBL] [Abstract][Full Text] [Related]
19. Serine/threonine phosphorylation of ShcA. Regulation of protein-tyrosine phosphatase-pest binding and involvement in insulin signaling.
Faisal A; el-Shemerly M; Hess D; Nagamine Y
J Biol Chem; 2002 Aug; 277(33):30144-52. PubMed ID: 12052829
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
